Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Boundless Bio, Inc. Common Stock
BOLDCurrent price
3.57 USD
-0.13 USD (-3.51%)
Last closed
3.7 USD
Company
boundlessbio.com
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
79 893 656 USD
Yield for 12 month
-74.95 %
1Y
3Y
5Y
10Y
15Y
BOLD
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California. Address: 9880 Campus Point Drive, San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
18.33 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-957 000 USD
Last Year
-942 000 USD
Current Quarter
-265 000 USD
Last Quarter
-263 000 USD
Key Figures BOLD
1 year
3 years
5 years
10 years
EBITDA
-64 013 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-23.69 %
PEG Ratio
–
Return On Equity TTM
-35.74 %
Wall Street Target Price
18.33 USD
Revenue TTM
–
Book Value
8.06 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.59 USD
Diluted Eps TTM
-2.59 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BOLD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BOLD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation BOLD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
–
Price Book MRQ
0.4457
Financials BOLD
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BOLD
For 52 weeks
2.82 USD
15.24 USD
50 Day MA
3.58 USD
Shares Short Prior Month
546 565
200 Day MA
6.91 USD
Short Ratio
10.24
Shares Short
265 787
Short Percent
4.34 %
BeatStart